MTBP regulates cell survival and therapeutic sensitivity in TP53 wildtype glioblastomas.
Background: Glioblastoma (GBM) is highly proliferative and resistant to radio-chemotherapy. Loss of tumor suppressor gene TP53 function frequently occurs at protein level in GBMs. This inhibition is often mediated by other components within the p53 signaling axis, including MDM2, whose binding protein (MTBP) plays an important role in the regulation ... of MDM2 and p53 activity. We investigated the role of MTBP in the biology of TP53-wildtype (TP53wt) GBMs. Methods: MTBP expression was examined in TCGA and REMBRANDT datasets. MTBP was silenced or overexpressed in TP53wt GBM cells and glioma stem cells (GSCs). The effects on cell viability, apoptosis, and clonogenicity were assessed. The transcriptional regulation of MTBP was investigated. Results: Upregulation of MTBP was correlated with the Classical molecular subtype, and it predicted poor survival. In TP53wt GBM cells, the protein levels of MTBP were positively associated with those of MDM2 but negatively correlated with those of p53. MTBP knockdown promoted apoptosis and inhibited clonogenicity, while overexpression of this protein enhanced tumorigenicity in vitro and in vivo. The pro-survival effect of MTBP depended on the activity of MDM2 and p53. MTBP was transcriptionally regulated by c-myc, thereby forming a positive regulatory loop. Finally, MTBP silencing increased the sensitivity of TP53wt GSCs to radiation and TMZ treatment in vitro and in vivo. Conclusion: MTBP regulates the cell survival and treatment sensitivity of TP53wt GBMs through MDM2-dependent post-translational modification of p53. MTBP-targeting treatments are potentially useful in increasing patients' survival.
Mesh Terms:
Animals, Antineoplastic Agents, Alkylating, Apoptosis, Blotting, Western, Carrier Proteins, Cell Line, Tumor, Cell Survival, Female, Flow Cytometry, Gene Expression Regulation, Neoplastic, Glioblastoma, Glioma, Humans, Immunohistochemistry, Immunoprecipitation, Mice, Mice, Inbred BALB C, Mice, Nude, Protein Processing, Post-Translational, Proto-Oncogene Proteins c-mdm2, Real-Time Polymerase Chain Reaction, Temozolomide, Tumor Suppressor Protein p53
Animals, Antineoplastic Agents, Alkylating, Apoptosis, Blotting, Western, Carrier Proteins, Cell Line, Tumor, Cell Survival, Female, Flow Cytometry, Gene Expression Regulation, Neoplastic, Glioblastoma, Glioma, Humans, Immunohistochemistry, Immunoprecipitation, Mice, Mice, Inbred BALB C, Mice, Nude, Protein Processing, Post-Translational, Proto-Oncogene Proteins c-mdm2, Real-Time Polymerase Chain Reaction, Temozolomide, Tumor Suppressor Protein p53
Theranostics
Date: Sep. 20, 2019
PubMed ID: 31534534
View in: Pubmed Google Scholar
Download Curated Data For This Publication
249382
Switch View:
- Interactions 3